Charisse R. Lillie - Mar 31, 2025 Form 4 Insider Report for EXELON CORP (EXC)

Role
Director
Signature
David T. Skinner, attorney-in-fact for Charisse R Lillie
Stock symbol
EXC
Transactions as of
Mar 31, 2025
Transactions value $
$41,229
Form type
4
Date filed
4/2/2025, 02:25 PM
Previous filing
Jan 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common stock- deferred stock units Award $41.2K +933 +12.37% $44.19 8.47K Mar 31, 2025 By Exelon Corp. Directors Deferred Stock Unit Plan F1
holding EXC Common Stock 7.25K Mar 31, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXC Deferred phantom share equivalents 3.72K Mar 31, 2025 Common Stock 3.72K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 68 additional shares acquired through automatic dividend reinvestment.
F2 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3 Balance includes 34 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.